{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T02:10:01Z","timestamp":1717553401714},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,11,12]],"date-time":"2014-11-12T00:00:00Z","timestamp":1415750400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00101-014-2392-x","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T20:52:45Z","timestamp":1415998365000},"page":"908-918","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Maligne Hyperthermie","Malignant hyperthermia"],"prefix":"10.1007","volume":"63","author":[{"given":"T.","family":"Metterlein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.M.","family":"Graf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Anetseder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,12]]},"reference":[{"key":"2392_CR1","unstructured":"Gibson C (1900) Heat stroke as a postoperative complication. Med News (NY) 883\u2013888"},{"key":"2392_CR2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00101-002-0314-9","volume":"51","author":"Steinfath","year":"2002","unstructured":"Steinfath M, Wappler F, Scholz J (2002) Malignant hyperthermia. General, clinical and experimental aspects. Anaesthesist 51:328\u2013345","journal-title":"Anaesthesist"},{"key":"2392_CR3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/bja\/34.6.395","volume":"34","author":"Denborough","year":"1962","unstructured":"Denborough MA, Forster JF, Lovell RR et al (1962) Anaesthetic deaths in a family. Br J Anaesth 34:395\u2013396","journal-title":"Br J Anaesth"},{"key":"2392_CR4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/bja\/52.2.165","volume":"52","author":"Hall","year":"1980","unstructured":"Hall GM, Lucke JN, Lister D (1980) Malignant hyperthermia \u2013 pearls out of swine? Br J Anaesth 52:165\u2013171","journal-title":"Br J Anaesth"},{"key":"2392_CR5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/s-2007-1000613","volume":"26","author":"Roewer","year":"1991","unstructured":"Roewer N (1991) Malignant hyperthermia today. Anasthesiol Intensivmed Notfallmed Schmerzther 26:431\u2013449","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"2392_CR6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/bja\/47.1.62","volume":"47","author":"Harrison","year":"1975","unstructured":"Harrison GG (1975) Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. Br J Anaesth 47:62\u201365","journal-title":"Br J Anaesth"},{"key":"2392_CR7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/bja\/45.6.638","volume":"45","author":"Ellis","year":"1973","unstructured":"Ellis FR, Harriman DG (1973) A new screening test for susceptibility to malignant hyperpyrexia. Br J Anaesth 45:638","journal-title":"Br J Anaesth"},{"key":"2392_CR8","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/bja\/56.11.1267","volume":"56","author":"European","year":"1984","unstructured":"European Malignant Hyperpyrexia Group (1984) A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. Br J Anaesth 56:1267\u20131269","journal-title":"Br J Anaesth"},{"key":"2392_CR9","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","volume":"97","author":"Monnier","year":"2002","unstructured":"Monnier N, Krivosic-Horber R, Payen JF et al (2002) Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anesthesiology 97:1067\u20131074","journal-title":"Anesthesiology"},{"key":"2392_CR10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00101-007-1218-5","volume":"56","author":"Ruffert","year":"2007","unstructured":"Ruffert H, Wehner M, Deutrich C, Olthoff D (2007) Malignant hyperthermia. The ugly. Anaesthesist 56:923\u2013929","journal-title":"Anaesthesist"},{"key":"2392_CR11","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1212\/WNL.44.12.2393","volume":"44","author":"Anetseder","year":"1994","unstructured":"Anetseder M, Hartung E, Klepper S, Reichmann H (1994) Gasoline vapors induce severe rhabdomyolysis. Neurology 44:2393\u20132395","journal-title":"Neurology"},{"key":"2392_CR12","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/bmj.296.6634.1442-a","volume":"J","author":"Denborough","year":"1988","unstructured":"Denborough MA, Hopkinson KC, Banney DG (1988) Firefighting and malignant hyperthermia. Br Med J (Clin Res Ed) 296:1442\u20131443","journal-title":"Br Med"},{"key":"2392_CR13","first-page":"700","volume":"64","author":"Ording","year":"1985","unstructured":"Ording H (1985) Incidence of malignant hyperthermia in Denmark. Anesth Analg 64:700\u2013704","journal-title":"Anesth Analg"},{"key":"2392_CR14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-2007-994238","volume":"33","author":"Hartung","year":"1998","unstructured":"Hartung E, Anetseder M, Olthoff D et al (1998) Regional distribution of predisposition to maligant hyperthermia in Germany: state in 1997. Anasthesiol Intensivmed Notfallmed Schmerzther 33:238\u2013243","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"2392_CR15","first-page":"w13652","volume":"142","author":"Bandschapp","year":"2012","unstructured":"Bandschapp O, Girard T (2012) Malignant hyperthermia. Swiss Med Wkly 142:w13652","journal-title":"Swiss Med Wkly"},{"key":"2392_CR16","doi-asserted-by":"crossref","first-page":"C66","DOI":"10.1152\/ajpcell.1982.243.1.C66","volume":"243","author":"Faulkner","year":"1982","unstructured":"Faulkner JA, Claflin DR, McCully KK, Jones DA (1982) Contractile properties of bundles of fiber segments from skeletal muscles. Am J Physiol 243:C66\u2013C73","journal-title":"Am J Physiol"},{"key":"2392_CR17","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s12630-013-0011-y","volume":"60","author":"Rosenberg","year":"2013","unstructured":"Rosenberg H (2013) Myopathic changes in malignant hyperthermia-susceptible patients. Can J Anaesth 60:955\u2013959","journal-title":"Can J Anaesth"},{"key":"2392_CR18","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1213\/ane.0b013e3181a7c8e5","volume":"109","author":"Parness","year":"2009","unstructured":"Parness J, Bandschapp O, Girard T (2009) The myotonias and susceptibility to malignant hyperthermia. Anesth Analg 109:1054\u20131064","journal-title":"Anesth Analg"},{"key":"2392_CR19","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1213\/ANE.0b013e3181b5ae2d","volume":"109","author":"Klingler","year":"2009","unstructured":"Klingler W, Rueffert H, Lehmann-Horn F et al (2009) Core myopathies and risk of malignant hyperthermia. Anesth Analg 109:1167\u20131173","journal-title":"Anesth Analg"},{"key":"2392_CR20","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/WCO.0b013e32832efa8f","volume":"22","author":"Platt","year":"2009","unstructured":"Platt D, Griggs R (2009) Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias. Curr Opin Neurol 22:524\u2013531","journal-title":"Curr Opin Neurol"},{"key":"2392_CR21","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1213\/ane.0b013e3181aa5cf6","volume":"109","author":"Gurnaney","year":"2009","unstructured":"Gurnaney H, Brown A, Litman RS (2009) Malignant hyperthermia and muscular dystrophies. Anesth Analg 109:1043\u20131048","journal-title":"Anesth Analg"},{"key":"2392_CR22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1213\/ane.0b013e3181adca28","volume":"109","author":"Benca","year":"2009","unstructured":"Benca J, Hogan K (2009) Malignant hyperthermia, coexisting disorders, and enzymopathies: risks and management options. Anesth Analg 109:1049\u20131053","journal-title":"Anesth Analg"},{"key":"2392_CR23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11914-007-0023-z","volume":"5","author":"Martin","year":"2007","unstructured":"Martin E, Shapiro JR (2007) Osteogenesis imperfecta: epidemiology and pathophysiology. Curr Osteoporos Rep 5:91\u201397","journal-title":"Curr Osteoporos Rep"},{"key":"2392_CR24","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1176\/appi.ajp.164.6.870","volume":"164","author":"Strawn","year":"2007","unstructured":"Strawn JR, Keck PE Jr, Caroff SN (2007) Neuroleptic malignant syndrome. Am J Psychiatry 164:870\u2013876","journal-title":"Am J Psychiatry"},{"key":"2392_CR25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-0028-1109297","volume":"77","author":"Huttemann","year":"2009","unstructured":"Huttemann K, Nowe T, Kohrmann M et al (2009) Malignant hyperthermia and its differential diagnosis. Fortschr Neurol Psychiatr 77:203\u2013211","journal-title":"Fortschr Neurol Psychiatr"},{"key":"2392_CR26","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/00000542-199306000-00018","volume":"78","author":"Wedel","year":"1993","unstructured":"Wedel DJ, Gammel SA, Milde JH, Iaizzo PA (1993) Delayed onset of malignant hyperthermia induced by isoflurane and desflurane compared with halothane in susceptible swine. Anesthesiology 78:1138\u20131144","journal-title":"Anesthesiology"},{"key":"2392_CR27","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1213\/ane.0b013e3181857903","volume":"107","author":"Girard","year":"2008","unstructured":"Girard T, Suhner M, Levano S et al (2008) A fulminant malignant hyperthermia episode in a patient with ryanodine receptor gene mutation p.Tyr522Ser. Anesth Analg 107:1953\u20131955","journal-title":"Anesth Analg"},{"key":"2392_CR28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1213\/01.ANE.0000068644.31333.BD","volume":"97","author":"Wappler","year":"2003","unstructured":"Wappler F, Fiege M (2003) Is desflurane a \u201eweak\u201c trigger of malignant hyperthermia? Anesth Analg 97:295","journal-title":"Anesth Analg"},{"key":"2392_CR29","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s001010050509","volume":"46","author":"Olthoff","year":"1997","unstructured":"Olthoff D, Vonderlind C (1997) Anesthesia unrelated triggering of a fatal malignant hyperthermia crisis. Anaesthesist 46:1076\u20131080","journal-title":"Anaesthesist"},{"key":"2392_CR30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00000542-200407000-00053","volume":"101","author":"Rusyniak","year":"2004","unstructured":"Rusyniak DE, Banks ML, Mills EM, Sprague JE (2004) Dantrolene use in 3,4-methylenedioxymethamphetamine (ecstasy)-mediated hyperthermia. Anesthesiology 101:263","journal-title":"Anesthesiology"},{"key":"2392_CR31","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1097\/00000542-199606000-00014","volume":"84","author":"Tegazzin","year":"1996","unstructured":"Tegazzin V, Scutari E, Treves S, Zorzato F (1996) Chlorocresol, an additive to commercial succinylcholine, induces contracture of human malignant hyperthermia-susceptible muscles via activation of the ryanodine receptor Ca2+ channel. Anesthesiology 84:1380\u20131385","journal-title":"Anesthesiology"},{"key":"2392_CR32","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/00000542-199906000-00031","volume":"90","author":"Wappler","year":"1999","unstructured":"Wappler F, Scholz J, Fiege M et al (1999) 4-chloro-m-cresol is a trigger of malignant hyperthermia in susceptible swine. Anesthesiology 90:1733\u20131740","journal-title":"Anesthesiology"},{"key":"2392_CR33","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1213\/ANE.0b013e31825d3749","volume":"115","author":"Johannsen","year":"2012","unstructured":"Johannsen S, Roewer N, Schuster F (2012) Ondansetron-induced muscular contractures in malignant hyperthermia-susceptible individuals. Anesth Analg 115:925\u2013928","journal-title":"Anesth Analg"},{"key":"2392_CR34","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1755-5922.2010.00237.x","volume":"28","author":"Metterlein","year":"2010","unstructured":"Metterlein T, Schuster F, Tadda L et al (2010) Statins alter intracellular calcium homeostasis in malignant hyperthermia susceptible individuals. Cardiovasc Ther 28:356\u2013360","journal-title":"Cardiovasc Ther"},{"key":"2392_CR35","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mus.22021","volume":"44","author":"Metterlein","year":"2011","unstructured":"Metterlein T, Schuster F, Tadda L et al (2011) Fluoroquinolones influence the intracellular calcium handling in individuals susceptible to malignant hyperthermia. Muscle Nerve 44(2):208\u2013212","journal-title":"Muscle Nerve"},{"key":"2392_CR36","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0140-6736(74)90105-6","volume":"2","author":"Wingard","year":"1974","unstructured":"Wingard DW (1974) Letter: malignant hyperthermia: a human stress syndrome? Lancet 2:1450\u20131451","journal-title":"Lancet"},{"key":"2392_CR37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00000542-197711000-00004","volume":"47","author":"Gronert","year":"1977","unstructured":"Gronert GA, Milde JH, Theye RA (1977) Role of sympathetic activity in porcine malignant hyperthermia. Anesthesiology 47:411\u2013415","journal-title":"Anesthesiology"},{"key":"2392_CR38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","volume":"2","author":"Rosenberg","year":"2007","unstructured":"Rosenberg H, Davis M, James D et al (2007) Malignant hyperthermia. Orphanet J Rare Dis 2:21","journal-title":"Orphanet J Rare Dis"},{"key":"2392_CR39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00000542-200101000-00019","volume":"94","author":"Wappler","year":"2001","unstructured":"Wappler F, Fiege M, Steinfath M et al (2001) Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis. Anesthesiology 94:95\u2013100","journal-title":"Anesthesiology"},{"key":"2392_CR40","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1529\/biophysj.104.048447","volume":"87","author":"Dirksen","year":"2004","unstructured":"Dirksen RT, Avila G (2004) Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1. Biophys J 87:3193\u20133204","journal-title":"Biophys J"},{"key":"2392_CR41","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1365-2044.1975.tb00861.x","volume":"30","author":"Hall","year":"1975","unstructured":"Hall GM, Lucke JN, Lister D (1975) Treatment of porcine malignant hyperthermia. A review based on experimental studies. Anaesthesia 30:308\u2013317","journal-title":"Anaesthesia"},{"key":"2392_CR42","first-page":"803","volume":"82","author":"Iaizzo","year":"1996","unstructured":"Iaizzo PA, Kehler CH, Carr RJ et al (1996) Prior hypothermia attenuates malignant hyperthermia in susceptible swine. Anesth Analg 82:803\u2013809","journal-title":"Anesth Analg"},{"key":"2392_CR43","first-page":"138","volume":"75","author":"Newson","year":"1972","unstructured":"Newson AJ (1972) Malignant hyperthermia: three case reports. N Z Med J 75:138\u2013143","journal-title":"N Z Med J"},{"key":"2392_CR44","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jtcvs.2011.01.034","volume":"141","author":"Metterlein","year":"2011","unstructured":"Metterlein T, Zink W, Kranke E et al (2011) Cardiopulmonary bypass in malignant hyperthermia susceptible patients: a systematic review of published cases. J Thorac Cardiovasc Surg 141:1488\u20131495","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2392_CR45","doi-asserted-by":"crossref","first-page":"26332","DOI":"10.1074\/jbc.272.42.26332","volume":"272","author":"Tong","year":"1997","unstructured":"Tong J, Oyamada H, Demaurex N et al (1997) Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and\/or central core disease. J Biol Chem 272:26332\u201326339","journal-title":"J Biol Chem"},{"key":"2392_CR46","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1365-2346.2001.00888.x","volume":"18","author":"Wappler","year":"2001","unstructured":"Wappler F (2001) Malignant hyperthermia. Eur J Anaesthesiol 18:632\u2013652","journal-title":"Eur J Anaesthesiol"},{"key":"2392_CR47","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.bbrc.2004.08.039","volume":"322","author":"Striessnig","year":"2004","unstructured":"Striessnig J, Hoda JC, Koschak A et al (2004) L-type Ca2+ channels in Ca2+ channelopathies. Biochem Biophys Res Commun 322:1341\u20131346","journal-title":"Biochem Biophys Res Commun"},{"key":"2392_CR48","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1085\/jgp.200910328","volume":"135","author":"Esteve","year":"2010","unstructured":"Esteve E, Eltit JM, Bannister RA et al (2010) A malignant hyperthermia-inducing mutation in RYR1 (R163C): alterations in Ca2+ entry, release, and retrograde signaling to the DHPR. J Gen Physiol 135:619\u2013628","journal-title":"J Gen Physiol"},{"key":"2392_CR49","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-201x.2001.00840.x","volume":"171","author":"Melzer","year":"2001","unstructured":"Melzer W, Dietze B (2001) Malignant hyperthermia and excitation-contraction coupling. Acta Physiol Scand 171:367\u2013378","journal-title":"Acta Physiol Scand"},{"key":"2392_CR50","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0006-3495(90)82563-7","volume":"57","author":"Fill","year":"1990","unstructured":"Fill M, Coronado R, Mickelson JR et al (1990) Abnormal ryanodine receptor channels in malignant hyperthermia. Biophys J 57:471\u2013475","journal-title":"Biophys J"},{"key":"2392_CR51","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/ALN.0b013e31818958e5","volume":"109","author":"Litman","year":"2008","unstructured":"Litman RS, Flood CD, Kaplan RF et al (2008) Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry. Anesthesiology 109:825\u2013829","journal-title":"Anesthesiology"},{"key":"2392_CR52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1213\/00000539-200301000-00034","volume":"96","author":"Hoenemann","year":"2003","unstructured":"Hoenemann CW, Halene-Holtgraeve TB, Booke M et al (2003) Delayed onset of malignant hyperthermia in desflurane anesthesia. Anesth Analg 96:165\u2013167 (table)","journal-title":"Anesth Analg"},{"key":"2392_CR53","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1460-9592.2006.02051.x","volume":"17","author":"Bonciu","year":"2007","unstructured":"Bonciu M, Chapelle A de la, Delpech H et al (2007) Minor increase of endtidal CO2 during sevoflurane-induced malignant hyperthermia. Paediatr Anaesth 17:180\u2013182","journal-title":"Paediatr Anaesth"},{"key":"2392_CR54","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.annfar.2009.09.008","volume":"28","author":"Barbier","year":"2009","unstructured":"Barbier M, Lafaye AL, Guerin R et al (2009) A case of malignant hyperthermia arising five hours after the beginning of anaesthesia with sevoflurane and after five uneventful surgical procedures. Ann Fr Anesth Reanim 28:983\u2013987","journal-title":"Ann Fr Anesth Reanim"},{"key":"2392_CR55","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1055\/s-0029-1242125","volume":"44","author":"Schuster","year":"2009","unstructured":"Schuster F, Muller-Reible CR (2009) Malignant hyperthermia \u2013 diagnostics, treatment and anaesthetic management. Anasthesiol Intensivmed Notfallmed Schmerzther 44:758\u2013763","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"2392_CR56","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1213\/ane.0b013e3181ae6b96","volume":"109","author":"Litman","year":"2009","unstructured":"Litman RS, Rosenberg H (2009) Malignant hyperthermia-associated diseases: state of the art uncertainty. Anesth Analg 109:1004\u20131005","journal-title":"Anesth Analg"},{"key":"2392_CR57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1055\/s-0033-1342900","volume":"48","author":"Schuster","year":"2013","unstructured":"Schuster F, Johannsen S, Roewer N (2013) Helsinki declaration on patient safety in anaesthesiology \u2013 part 3: SOP for malignant hyperthermia. Anasthesiol Intensivmed Notfallmed Schmerzther 48:162\u2013164","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"2392_CR58","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","volume":"80","author":"Larach","year":"1994","unstructured":"Larach MG, Localio AR, Allen GC et al (1994) A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology 80:771\u2013779","journal-title":"Anesthesiology"},{"key":"2392_CR59","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-2007-994239","volume":"33","author":"Richthofen","year":"1998","unstructured":"Richthofen V von, Wappler F, Scholz J et al (1998) Evaluation of malignant hyperthermia episodes with the Clinical Grading Scale. Anasthesiol Intensivmed Notfallmed Schmerzther 33:244\u2013249","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"2392_CR60","first-page":"483","volume":"49","author":"DGAI","year":"2008","unstructured":"DGAI (2008) Maligne Hyperthermie. Anaesth Intensivmed 49:483\u2013488","journal-title":"Anaesth Intensivmed"},{"key":"2392_CR61","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/bja\/aeq243","volume":"105","author":"Glahn","year":"2010","unstructured":"Glahn KP, Ellis FR, Halsall PJ et al (2010) Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group. Br J Anaesth 105:417\u2013420","journal-title":"Br J Anaesth"},{"key":"2392_CR62","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1365-2044.1993.tb07414.x","volume":"48","author":"Reber","year":"1993","unstructured":"Reber A, Schumacher P, Urwyler A (1993) Effects of three different types of management on the elimination kinetics of volatile anaesthetics. Implications for malignant hyperthermia treatment. Anaesthesia 48:862\u2013865","journal-title":"Anaesthesia"},{"key":"2392_CR63","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1213\/01.ANE.0000184184.40504.F3","volume":"101","author":"Podranski","year":"2005","unstructured":"Podranski T, Bouillon T, Schumacher PM et al (2005) Compartmental pharmacokinetics of dantrolene in adults: do malignant hyperthermia association dosing guidelines work? Anesth Analg 101:1695\u20131699","journal-title":"Anesth Analg"},{"key":"2392_CR64","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00101-003-0461-7","volume":"52","author":"Gerbershagen","year":"2003","unstructured":"Gerbershagen MU, Fiege M, Krause T et al (2003) Dantrolene. Pharmacological and therapeutic aspects. Anaesthesist 52:238\u2013245","journal-title":"Anaesthesist"},{"key":"2392_CR65","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1939-1676.2010.0556.x","volume":"24","author":"Carmo","year":"2010","unstructured":"Carmo PL do, Zapata-Sudo G, Trachez MM et al (2010) Intravenous administration of azumolene to reverse malignant hyperthermia in swine. J Vet Intern Med 24:1224\u20131228","journal-title":"J Vet Intern Med"},{"key":"2392_CR66","unstructured":"Beker S (2007) Vergleich der therapeutischen Effektivit\u00e4t des Dantrolens zu der neuen hydrophilen Dantrolen-Formulierung (Ryanodex) in Maligne Hyperthermie positiven Schweinen. EMHG Meeting, Riga, 16.05.2007"},{"key":"2392_CR67","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00540-012-1347-0","volume":"26","author":"Migita","year":"2012","unstructured":"Migita T, Mukaida K, Yasuda T et al (2012) Calcium channel blockers are inadequate for malignant hyperthermia crisis. J Anesth 26:579\u2013584","journal-title":"J Anesth"},{"key":"2392_CR68","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra0801327","volume":"361","author":"Bosch","year":"2009","unstructured":"Bosch X, Poch E, Grau JM (2009) Rhabdomyolysis and acute kidney injury. N Engl J Med 361:62\u201372","journal-title":"N Engl J Med"},{"key":"2392_CR69","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1213\/ANE.0b013e31821263d6","volume":"112","author":"Metterlein","year":"2011","unstructured":"Metterlein T, Schuster F, Kranke P et al (2011) Magnesium does not influence the clinical course of succinylcholine-induced malignant hyperthermia. Anesth Analg 112:1174\u20131178","journal-title":"Anesth Analg"},{"key":"2392_CR70","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-2007-1002547","volume":"22","author":"Schulte-Sasse","year":"1987","unstructured":"Schulte-Sasse U, Eberlein HJ (1987) \u201eRound the clock\u201c \u2013 an information service for malignant hyperthermia emergencies. Anasth Intensivther Notfallmed 22:249","journal-title":"Anasth Intensivther Notfallmed"},{"key":"2392_CR71","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00000542-200201000-00036","volume":"96","author":"Rosenberg","year":"2002","unstructured":"Rosenberg H, Antognini JF, Muldoon S (2002) Testing for malignant hyperthermia. Anesthesiology 96:232\u2013237","journal-title":"Anesthesiology"},{"key":"2392_CR72","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","volume":"41","author":"Ording","year":"1997","unstructured":"Ording H, Brancadoro V, Cozzolino S et al (1997) In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand 41:955\u2013966","journal-title":"Acta Anaesthesiol Scand"},{"key":"2392_CR73","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00000542-199307000-00003","volume":"79","author":"Isaacs","year":"1993","unstructured":"Isaacs H, Badenhorst M (1993) False-negative results with muscle caffeine halothane contracture testing for malignant hyperthermia. Anesthesiology 79:5\u20139","journal-title":"Anesthesiology"},{"key":"2392_CR74","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1001\/jama.293.23.2918","volume":"293","author":"Litman","year":"2005","unstructured":"Litman RS, Rosenberg H (2005) Malignant hyperthermia: update on susceptibility testing. JAMA 293:2918\u20132924","journal-title":"JAMA"},{"key":"2392_CR75","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/343562a0","volume":"343","author":"McCarthy","year":"1990","unstructured":"McCarthy TV, Healy JM, Heffron JJ et al (1990) Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2. Nature 343:562\u2013564","journal-title":"Nature"},{"key":"2392_CR76","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/343559a0","volume":"343","author":"MacLennan","year":"1990","unstructured":"MacLennan DH, Duff C, Zorzato F et al (1990) Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature 343:559\u2013561","journal-title":"Nature"},{"key":"2392_CR77","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/geno.1996.0238","volume":"34","author":"Phillips","year":"1996","unstructured":"Phillips MS, Fujii J, Khanna VK et al (1996) The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene. Genomics 34:24\u201341","journal-title":"Genomics"},{"key":"2392_CR78","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","volume":"27","author":"Robinson","year":"2006","unstructured":"Robinson R, Carpenter D, Shaw MA et al (2006) Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 27:977\u2013989","journal-title":"Hum Mutat"},{"key":"2392_CR79","unstructured":"o A (2010) European Malignant Hyperthermia Group: EMHG"},{"key":"2392_CR80","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1213\/ANE.0000000000000063","volume":"118","author":"Stowell","year":"2014","unstructured":"Stowell KM (2014) DNA testing for malignant hyperthermia: the reality and the dream. Anesth Analg 118:397\u2013406","journal-title":"Anesth Analg"},{"key":"2392_CR81","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","volume":"86","author":"Urwyler","year":"2001","unstructured":"Urwyler A, Deufel T, McCarthy T, West S (2001) Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth 86:283\u2013287","journal-title":"Br J Anaesth"},{"key":"2392_CR82","first-page":"1334","volume":"56","author":"Deufel","year":"1995","unstructured":"Deufel T, Sudbrak R, Feist Y et al (1995) Discordance, in a malignant hyperthermia pedigree, between in vitro contracture-test phenotypes and haplotypes for the MHS1 region on chromosome 19q12-13.2, comprising the C1840T transition in the RYR1 gene. Am J Hum Genet 56:1334\u20131342","journal-title":"Am J Hum Genet"},{"key":"2392_CR83","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.ejhg.5200964","volume":"11","author":"Robinson","year":"2003","unstructured":"Robinson RL, Anetseder MJ, Brancadoro V et al (2003) Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing? Eur J Hum Genet 11:342\u2013348","journal-title":"Eur J Hum Genet"},{"key":"2392_CR84","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1097\/00000542-200606000-00014","volume":"104","author":"McKinney","year":"2006","unstructured":"McKinney LC, Butler T, Mullen SP, Klein MG (2006) Characterization of ryanodine receptor-mediated calcium release in human B cells: relevance to diagnostic testing for malignant hyperthermia. Anesthesiology 104:1191\u20131201","journal-title":"Anesthesiology"},{"key":"2392_CR85","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(02)08506-9","volume":"359","author":"Anetseder","year":"2002","unstructured":"Anetseder M, Hager M, Muller CR, Roewer N (2002) Diagnosis of susceptibility to malignant hyperthermia by use of a metabolic test. Lancet 359:1579\u20131580","journal-title":"Lancet"},{"key":"2392_CR86","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00101-008-1399-6","volume":"57","author":"Schuster","year":"2008","unstructured":"Schuster F, Hager M, Metterlein T et al (2008) In-vivo diagnosis of malignant hyperthermia susceptibility: a microdialysis study. Anaesthesist 57:767\u2013774","journal-title":"Anaesthesist"},{"key":"2392_CR87","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1213\/ane.0b013e31817e60b5","volume":"107","author":"Schuster","year":"2008","unstructured":"Schuster F, Metterlein T, Negele S et al (2008) An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study. Anesth Analg 107:909\u2013914","journal-title":"Anesth Analg"},{"key":"2392_CR88","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/pan.12234","volume":"23","author":"Kim","year":"2013","unstructured":"Kim TW, Tham RQ (2013) Washout times of desflurane, sevoflurane and isoflurane from the GE Healthcare Aisys(R) and Avance(R), Carestation(R), and Aestiva(R) anesthesia system. Paediatr Anaesth 23:1124\u20131130","journal-title":"Paediatr Anaesth"},{"key":"2392_CR89","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF03010703","volume":"42","author":"Carr","year":"1995","unstructured":"Carr AS, Lerman J, Cunliffe M et al (1995) Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy. Can J Anaesth 42:281\u2013286","journal-title":"Can J Anaesth"},{"key":"2392_CR90","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1589759","volume":"256","author":"MacLennan","year":"1992","unstructured":"MacLennan DH, Phillips MS (1992) Malignant hyperthermia. Science 256:789\u2013794","journal-title":"Science"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-014-2392-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-014-2392-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-014-2392-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T01:33:49Z","timestamp":1717551229000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-014-2392-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,12]]},"references-count":90,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2392"],"URL":"https:\/\/doi.org\/10.1007\/s00101-014-2392-x","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,12]]}}}